Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 94 results.
User Information
Export Records
  1. 1.   Safety and immunogenicity of Innovax bivalent human papillomavirus vaccine in girls 9-14 years of age: Interim analysis from a phase 3 clinical trial
  2. Zaman, Khalequ; Schuind, Anne E; Adjei, Samuel; Antony, Kalpana; Aponte, John J; Buabeng, Patrick By; Qadri, Firdausi; Kemp,Troy; Hossain, Lokman; Pinto,Ligia; Sukraw, Kristen; Bhat, Niranjan; Agbenyega, Tsiri
  3. Vaccine. 2024, Apr 2; 42(9): 2290-2298.
  1. 2.   The progressive spectral signal-to-noise ratio of cryo-electron micrograph movies as a tool to assess quality and radiation damage
  2. Heymann,Bernard
  3. Computer Methods and Programs in Biomedicine. 2022, Apr 03; 220: 106799.
  1. 3.   Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial
  2. Porras, Carolina; Sampson, Joshua N.; Herrero, Rolando; Gail, Mitchell H.; Cortes, Bernal; Hildesheim, Allan; Cyr, Jean; Romero, Byron; Schiller, John T.; Montero, Christian; Pinto,Ligia; Schussler, John; Coronado, Karla; Sierra, Monica S.; Kim, Jane J.; Torres, Catherine M.; Carvajal, Loretto; Wagner,Sarah; Campos, Nicole G.; Ocampo, Rebecca; Kemp, Troy J.; Zuniga, Michael; Lowy, Douglas R.; Avila, Carlos; Chanock, Stephen; Castrillo, Ariane; Estrada, Yenory; Barrientos, Gloriana; Monge, Cindy; Oconitrillo, Maria Y.; Kreimer, Aimee R.
  3. Vaccine. 2022, Jan 3; 40(1): 76-88.
  1. 4.   PI3K inhibitors: review and new strategies
  2. Zhang,Mingzhen; Jang,Hyunbum; Nussinov,Ruth
  3. CHEMICAL SCIENCE. 2020, JUN 21; 11(23): 5855-5865.
  1. 5.   Genomic mapping in outbred mice reveals overlap in genetic susceptibility for HZE ion- and gamma-ray-induced tumors
  2. Edmondson,Elijah; Gatti, D. M.; Ray, F. A.; Garcia, E. L.; Fallgren, C. M.; Kamstock, D. A.; Weil, M. M.
  3. SCIENCE ADVANCES. 2020, Apr; 6(16): eaax5940.
  1. 6.   Linked dual-class HIV resistance mutations are associated with treatment failure
  2. Boltz,Valerie; Shao,Wei; Bale,Michael; Halvas, Elias; Luke,Brian; McIntyre, James A.; Schooley, Robert T.; Lockman, Shahin; Currier, Judith S.; Sawe, Fred; Hogg, Evelyn; Hughes, Michael D.; Kearney,Mary; Coffin, John M.; Mellors, John W.
  3. JCI INSIGHT. 2019, OCT 3; 4(19):
  1. 7.   Design and performance of the micro-dose calibrator
  2. Adler, Stephen; Choyke, Peter
  3. Physics in Medicine and Biology. 2018, Sep 10; 63(18):
  1. 8.   Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies
  2. Kreimer, Aimée R; Herrero, Rolando; Sampson, Joshua N; Porras, Carolina; Lowy, Douglas R; Schiller, John T; Schiffman, Mark; Rodriguez, Ana Cecilia; Chanock, Stephen; Jimenez, Silvia; Schussler, John; Gail, Mitchell H; Safaeian, Mahboobeh; Kemp, Troy; Cortes, Bernal; Pinto, Ligia; Hildesheim, Allan; Gonzalez, Paula
  3. Vaccine. 2018, Aug 06; 36(32 Pt. A): 4774-4782.
  1. 9.   Killer immunoglobulin-like receptor (KIR) and KIR-ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2
  2. Wang, W.; Erbe, A. K.; Gallenberger, M.; Kim, K.; Carmichael, L.; Hess, D.; Mendonca, E. A.; Song, Y.; Hank, J. A.; Cheng, S. C.; Signoretti, S.; Atkins, M.; Carlson, A.; Weiss, J. M.; Mier, J.; Panka, D.; McDermott, D. F.; Sondel, P. M.
  3. Cancer immunology, immunotherapy : CII. 2016, Dec; 65(12): 1523-1532.
  1. 10.   Enhanced Control of Pathogenic Simian Immunodeficiency Virus SIVmac239 Replication in Macaques Immunized with an Interleukin-12 Plasmid and a DNA Prime-Viral Vector Boost Vaccine Regimen
  2. Winstone, N.; Wilson, A. J.; Morrow, G.; Boggiano, C.; Chiuchiolo, M. J.; Lopez, M.; Kemelman, M.; Ginsberg, A. A.; Mullen, K.; Coleman, J. W.; Wu, C. D.; Narpala, S.; Ouellette, I.; Dean, H. J.; Lin, F.; Sardesai, N. Y.; Cassamasa, H.; McBride, D.; Felber, B. K.; Pavlakis, G. N.; Schultz, A.; Hudgens, M. G.; King, C. R.; Zamb, T. J.; Parks, C. L.; McDermott, A. B.
  3. Journal of Virology. 2011, Sep; 85(18): 9578-9587.
  1. 11.   Lack of Effect from a Previous Single Dose of Nevirapine on Virologic and Immunologic Responses After 6 Months of Antiretroviral Regimens Containing Either Efavirenz or Lopinavir-Ritonavir
  2. Dlamini, J. N.; Hu, Z. H.; Somaroo, H.; Highbarger, H. C.; Follmann, D. A.; Dewar, R. L.; Pau, A. K.
  3. Pharmacotherapy. 2011, Feb; 31(2): 158-163.
  1. 12.   Translational considerations for cancer nanomedicine
  2. Stern, S. T.; Hall, J. B.; Yu, L. L.; Wood, L. J.; Paciotti, G. F.; Tamarkin, L.; Long, S. E.; McNeil, S. E.
  3. Journal of Controlled Release. 2010, Sep; 146(2): 164-174.
  1. 13.   Mutagenicity of N-ethyl-N-nitrosourea, N-methyl-N-nitrosourea, methyl methanesulfonate and ethyl methanesulfonate in the developing Syrian hamster fetus
  2. Donovan, P.; Smith, G.
  3. Mutation Research-Genetic Toxicology and Environmental Mutagenesis. 2010, Jun; 699(1-2): 55-57.
  1. 14.   Low Frequency Nonnucleoside Reverse-Transcriptase Inhibitor-Resistant Variants Contribute to Failure of Efavirenz-Containing Regimens in Treatment-Experienced Patients
  2. Halvas, E. K.; Wiegand, A.; Boltz, V. F.; Kearney, M.; Nissley, D.; Wantman, M.; Hammer, S. M.; Palmer, S.; Vaida, F.; Coffin, J. M.; Mellors, J. W.
  3. Journal of Infectious Diseases. 2010, Mar; 201(5): 672-680.
  1. 15.   Optimization of allele-specific PCR using patient-specific HIV consensus sequences for primer design
  2. Boltz, V. F.; Maldarelli, F.; Martinson, N.; Morris, L.; McIntyre, J. A.; Gray, G.; Hopley, M. J.; Kimura, T.; Mayers, D. L.; Robinson, P.; Mellors, J. W.; Coffin, J. M.; Palmer, S. E.
  3. Journal of Virological Methods. 2010, Mar; 164(1-2): 122-126.
  1. 16.   Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow
  2. Salcedo, R.; Hixon, J. A.; Stauffer, J. K.; Jalah, R.; Brooks, A. D.; Khan, T.; Dai, R. M.; Scheetz, L.; Lincoln, E.; Back, T. C.; Powell, D.; Hurwitz, A. A.; Sayers, T. J.; Kastelein, R.; Pavlakis, G. N.; Felber, B. K.; Trinchieri, G.; Wigginton, J.
  3. Journal of Immunology. 2009 182(7): 4328-4338.
  1. 17.   Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge
  2. Wilson, N. A.; Keele, B. F.; Reed, J. S.; Piaskowski, S. M.; MacNair, C. E.; Bett, A. J.; Liang, X. P.; Wang, F. B.; Thoryk, E.; Heidecker, G. J.; Citron, M. P.; Huang, L. Y.; Lin, J.; Vitelli, S.; Ahn, C. D.; Kaizu, M.; Maness, N. J.; Reynolds, M. R.
  3. Journal of Virology. 2009 83(13): 6508-6521.
  1. 18.   Lack of ABC transporter autoinduction in mice following long-term exposure to imatinib
  2. Gardner, E. R.; Sparreboom, A.; Verweij, J.; Figg, W. D.
  3. Cancer Biology & Therapy. 2008 7(3): 412-415.
  1. 19.   A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas
  2. Mackall, C. L.; Rhee, E. H.; Read, E. J.; Khuu, H. M.; Leitman, S. F.; Bernstein, D.; Tesso, M.; Long, L. M.; Grindler, D.; Merino, M.; Kopp, W.; Tsokos, M.; Berzofsky, J. A.; Helman, L. J.
  3. Clinical Cancer Research. 2008 14(15): 4850-4858.
  1. 20.   Cytochrome P4502B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda
  2. Penzak, S. R.; Kabuye, G.; Mugyenyi, P.; Mbamanya, F.; Natarajan, V.; Alfaro, R. M.; Kityo, C.; Formentini, E.; Masur, H.
  3. HIV Medicine. 2007, Mar; 8(2): 86-91.
  1. 21.   2007 highlights of advances in the pharmaceutical sciences: An American association of pharmaceutical scientists (AAPS) perspective
  2. Martinez, M. N.; Bonate, P.; Chapman, R. L.; De Groot, A.; D'Souza, S.; Ghilazi, N.; Gray, V.; Gupta, V. K.; Huynh-Ba, K.; Iyer, S.; Jayatilaka, A.; Joshi, A.; Karnes, H. T.; Khan, M.; Liu, P.; Lunte, C.; McCurdy, C. R.; Morris, M. E.; Norris, K. J.; Ramsey, P.; Sehgal, S.; Zahn, M.
  3. Aaps Journal. 2007 9(2): E219-E226.
  1. 22.   Hypersusceptibility to cisplatin carcinogenicity in metallothionein-I/II double knockout mice: Production of hepatocellular carcinoma at clinically relevant doses
  2. Waalkes, M. P.; Liu, J.; Kasprzak, K. S.; Diwan, B. A.
  3. International Journal of Cancer. 2006, JUL 1; 119(1): 28-32.
  1. 23.   Lack of sex-related differences in saquinavir pharmacokinetics in an HIV-seronegative cohort
  2. Robertson, S. M.; Formentini, E.; Alfaro, R. M.; Natarajan, V.; Falloon, J.; Penzak, S. R.
  3. British Journal of Clinical Pharmacology. 2006, Apr; 61(4): 379-388.
  1. 24.   Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy
  2. Palmer, S.; Boltz, V.; Maldarelli, F.; Kearney, M.; Halvas, E. K.; Rock, D.; Falloon, J.; Davey, R. T.; Dewar, R. L.; Metcalf, J. A.; Mellors, J. W.; Coffin, J. M.
  3. Aids. 2006, Mar; 20(5): 701-710.
  1. 25.   A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins
  2. Townsend, D. M.; Findlay, V. J.; Fazilev, F.; Ogle, M.; Fraser, J.; Saavedra, J. E.; Ji, X. H.; Keefer, L. K.; Tew, K. D.
  3. Molecular Pharmacology. 2006, FEB; 69(2): 501-508.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel